OraSure Technologies | OSUR - 现金及等价物



金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 217.7M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


现金及等价物 更改 日
Agilent USD 1.76B 31M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 293.1M 201.1M 2025-09
Cerus USD 19.96M 4.29M 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Dexcom USD 1.12B 200.5M 2026-03
Illumina USD 1.42B 368M 2025-12
Integra LifeSciences USD 236.81M 1.76M 2026-03
Intuitive Surgical USD 7.98B 1.05B 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Quidel USD 169.8M 71.7M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
STAAR Surgical USD 153.15M 23M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Trinity Biotech USD 1.34M 3.83M 2025-09
Waters USD 587.83M 128.71M 2025-12